Ethical Division
The Ethical Business Division of Ind-Swift Laboratories Ltd. serves as a strategic growth driver for the company, focusing on the ethical promotion and pan-India marketing of our product portfolios. Anchored in scientific credibility, therapeutic relevance, and field-level excellence, this division plays a pivotal role in shaping our engagement with healthcare professionals across diverse specialties, while also maintaining a strong focus on delivering better outcomes for patients through responsible and accessible healthcare solutions.
Built on the foundation of quality, compliance, and responsible communication, the division delivers a strong and consistent message - healthcare solutions that are clinically validated, patient-centric, and aligned with evolving medical needs. With a strong presence across multiple therapy areas and first-time product introduction in India, the division continues to lead with innovation and trust.
Therapeutic Segments We Represent
The Ethical Business Division of Ind-Swift Laboratories manages a focused yet diverse portfolio of prescription medicines and Ayurvedic products across key therapeutic domains. Our core strengths lie in the following primary segments:
- Gynaecology
- Paediatrics
- General Healthcare
- Ayurvedic Range
These segments represent the foundation of our therapeutic strategy, supported by deep market insights, targeted scientific promotions, and strong brand recall among prescribers.
In addition, our General Healthcare portfolio includes trusted and widely prescribed solutions for:
- Orthopedics and Musculoskeletal Support
- Pain and Fever Management
- Gastrointestinal Health
- Anti-Infectives and Antibiotics
- Nutraceuticals
Each therapeutic area benefits from segment-specific communication, clinically relevant offerings, and continuous portfolio evolution in line with medical needs and patient outcomes.